Observational studyHaematologica2019
A prospective description of HIV-associated multicentric Castleman disease in Malawi.
Abstract readLetterObservational Study
In one paragraph
Observational study in Haematologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Serum Biomarkers in Advanced-Stage AIDS-Associated Kaposi Sarcoma in Resource Limited Settings.Journal of acquired immune deficiency syndromes (1999) · 2026Trial
- HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus.Clinical microbiology reviews · 2024Review
- Hematological Complications of Human Immunodeficiency Virus (HIV) Infection: An Update From an HIV-Endemic Setting.Open forum infectious diseases · 2024Review
- Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines.Scientific reports · 2024Article
- Addressing the Intersectional Stigma of Kaposi Sarcoma and HIV: A Call to Action.JCO global oncology · 2024Article
- Update on pathology laboratory development and research in advancing regional cancer care in Malawi.Frontiers in medicine · 2024Article
- A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory.International journal of cancer · 2023Article
- The case for prioritizing malignant hematology services in low- and middle-income countries.Seminars in hematology · 2023Article
- Malignancy and viral infections in Sub-Saharan Africa: A review.Frontiers in virology (Lausanne, Switzerland) · 2023Article
- Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi.Frontiers in oncology · 2022Article
- Navigating the heterogeneous landscape of pediatric Kaposi sarcoma.Cancer metastasis reviews · 2019Review
- Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies.Expert review of anti-infective therapyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Tamiwe TomokaDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA ttomoka@unclilongwe.org.
Matthew S PainschabMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Nathan D MontgomeryDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA.
Ryan SeguinMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Maurice MulengaMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Bongani KaimilaMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Edwards KasonkanjiMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Takondwa ZuzeMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Richard NyasoselaMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Ruth NyirendaMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Maria ChikasemaMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Blessings TeweteMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Asekanadziwa MtangwanikaMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Sarah ChiyoyolaMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Fred ChimzimuMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Coxcilly KampaniMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Yuri FedoriwDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA.
Satish GopalMalawi Cancer Consortium and Regional Center of Research Excellence for NCDs, Lilongwe, Malawi.
Funding
Consortium for Advancing Management and Prevention of Cancer in People with HIVUM1CA121947 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Joseph A. Sparano · 2015 to 2026
$253.7MVirology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5MVirology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9MSUPPORTING THE SCALE-UP HIGH QUALITY HIV CARE AND TREATMENT PROGRAMS IN MALAWI U2GPS001965 · PS · UNIVERSITY OF MALAWI · PI KAMIZA, DR. STEVE · 2009 to 2014
$12.9MProject 3U54CA190152 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAMANIA, BLOSSOM A, GOPAL, SATISH · 2014 to 2019
$4.2MDeveloping a clinical cohort of histopathologically characterized lymphomaK01TW009488 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GOPAL, SATISH · 2012 to 2016
$701kPlanning for a National Non-Communicable Disease Center of Research ExcellenceP20CA210285 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HOFFMAN, IRVING F. · 2016 to 2017
$517kMolecular profiling of HIV-associated lymphoma in the US and MalawiR21CA180815 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GOPAL, SATISH · 2013 to 2014
$341kFIC NIH HHS K01 TW009488NCHHSTP CDC HHS U2G PS001965NCI NIH HHS L30 CA233709NCI NIH HHS P20 CA210285NCI NIH HHS P30 CA016086NCI NIH HHS R21 CA180815NCI NIH HHS U54 CA190152NCI NIH HHS UM1 CA121947NIAID NIH HHS P30 AI050410
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAntineoplastic Combined Chemotherapy ProtocolsAnti-Retroviral AgentsCase-Control StudiesCastleman DiseaseDrug Therapy, CombinationFemaleFollow-Up StudiesHIVHIV InfectionsHumansMalawiMaleMiddle AgedPrognosisProspective StudiesAnti-Retroviral Agents
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.